Glycocalyx biomarkers as early predictors of endotheliopathy in pediatric and young adult hematopoietic stem cell transplantation patients.
Saved in:
| Title: | Glycocalyx biomarkers as early predictors of endotheliopathy in pediatric and young adult hematopoietic stem cell transplantation patients. |
|---|---|
| Authors: | Uchida K; Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.; Department of Pediatrics, Division of Pediatric Critical Care Medicine, The University of Tennessee Health Science Center, Memphis, TN, United States.; Department of Pediatrics, Division of Pediatric Critical Care, University of Utah Health, Salt Lake, UT, United States., Mahadeo KM; Department of Pediatrics, Division of Pediatric Transplantation and Cellular Therapy, Duke University, Durham, NC, United States., McArthur J; Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.; Department of Pediatrics, Division of Pediatric Critical Care Medicine, The University of Tennessee Health Science Center, Memphis, TN, United States., Avent Y; Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States., Hsu CW; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, United States., Pan H; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, United States., Elbahlawan L; Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States., Hines M; Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States., Sharma A; Department of Bone Marrow Transplantation & Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, United States., Tatevossian RG; Clinical Biomarkers Laboratory, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, United States., Mahapatra S; Clinical Biomarkers Laboratory, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, United States., Kumbaji M; Clinical Biomarkers Laboratory, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, United States., Sheikh I; Department of Stem Cell Transplantation, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Li Y; Department of Bone Marrow Transplantation & Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, United States., Schadler K; Department of Pediatrics Research, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ghafoor S; Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.; Department of Pediatrics, Division of Pediatric Critical Care Medicine, The University of Tennessee Health Science Center, Memphis, TN, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2026 May 08; Vol. 16, pp. 1789000. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1789000 |
